The Kennel Club is hosting a series of free webinars for owners and breeders who would like to find out more about the complexities of canine cancer and the impact of future research into the disease.
The first of this series, organised by The Kennel Club’s health team and taking place via Microsoft Teams on Thursday 22 June from 7pm to 8.30pm, will focus on osteosarcoma.
Osteosarcoma is an aggressive bone cancer that is unfortunately common in larger dogs and has been is identified as a priority condition through The Kennel Club’s Breed Health and Conservation Plan project.
The osteosarcoma webinar will include a presentation from specialist Professor Mark Dunning, who has led various osteosarcoma research projects at the University of Nottingham.
Professor Dunning will discuss disease progression, possible treatment options, what research has told us to date and how owners can best support their dogs affected with the condition.
This will be followed by a question and answer session, giving the osteosarcoma webinar attendees a chance to put forward their queries and experiences for discussion (questions can also be pre-submitted at the time of registration).
Those interested in attending the osteosarcoma webinar can register on the website.
Cancer is sadly a common disease of all dogs; statistics suggest around one in three dogs develop cancer in their lifetime.
So far this year, The Kennel Club’s health-focused webinar series have explored conditions such as canine epilepsy and colour dilution alopecia, as well as the science of DNA testing for health, with experts, researchers, owners and breeders.
The webinars aim to raise awareness of various canine health concerns, explore research and future studies, improve diagnosis and outlook, and support dogs affected with the condition, and their owners. Past webinars can be watched on their YouTube page.
More information about what The Kennel Club does for dog health is available on their website or by emailing in.
You can register for the osteosarcoma webinar on the website as well.
